October 9, 2007 - Medtronic Inc. will provide a synopsis of clinical data on the Endeavor Drug Eluting Coronary Stent to ...
October 9, 2007 - Physio-Control Inc., a wholly owned subsidiary of Medtronic, Inc., today announced that the LUCAS Chest Compression System is available in the U.S. through an exclusive distribution partnership with JOLIFE AB, expanding its reach of its emergency medicine device portfolio.
October 9, 2007 - OmniSonics Medical Technologies Inc. has received clearance from the FDA to market its catheter based OmniWave Endovascular System for the infusion of physician specified fluids, including thrombolytics, and for the removal of thrombus in the peripheral vasculature, as the company targets the deep vein thrombosis (DVT) market.
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
October 9, 2007 - Luna Innovations Inc. has entered into a joint marketing alliance agreement with Terumo Cardiovascular Systems Corp. (Terumo CVS), in which Luna and Terumo CVS will market Luna’s EDAC (Emboli Detection and Classification) Quantifier, as part of Luna's strategy to expand its presence in the U.S.
October 9, 2007 - Physio-Control Inc., a wholly owned subsidiary of Medtronic, Inc., will introduce the LUCAS Chest Compression System in the United States through an exclusive distribution partnership with JOLIFE AB, expanding the reach of its emergency medicine device portfolio.
October 9, 2007 - OmniSonics Medical Technologies Inc. has received clearance from the FDA to market its catheter based OmniWave Endovascular System for the infusion of physician specified fluids, including thrombolytics, and for the removal of thrombus in the peripheral vasculature, as the company targets the deep vein thrombosis (DVT) market.
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
October 9, 2007 – Medtronic Inc. today announced that it has begun enrolling in the PRECEDE-HF clinical trial that will evaluate Medtronic’s proprietary Cardiac Compass and OptiVol Fluid Status Monitoring features to determine whether cardiac trend data may help physicians prevent heart failure hospitalizations or deaths compared to standard clinical assessment alone.
October 8, 2007 - Cincinnati Sub-Zero (CSZ) Products Inc. released its Kool Kit noninvasive, integrated, whole-body hypothermia system in September.
October 8, 2007 - Enova Medical Technologies said today it developed new LED technology for cordless surgical headlights ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
October 8, 2007 - Drug-eluting stents were found to be most effective in reducing the need for repeat angioplasty ...
October 5, 2007 - InSite One Inc. recently announced the signing of a co-marketing agreement with Technology Imaging ...
October 5, 2007 – Royal Philips Electronics announced it will acquire U.S.-based Raytel Cardiac Services, a division of ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
October 4, 2007 – Aloka recently announced that the company will unveil three new models of its ProSound Systems, the ...
October 4, 2007 – The Cleveland Clinic announced Oct. 3 its Top 10 Medical Innovations list, highlighting technologies ...
October 4, 2007 – The acute success rate in patients treated for atrial fibrillation with the Niobe magnetic navigation ...
October 08, 2007
